Lynparza in combination with Abiraterone and Prednisone approved in the EU as treatment for metastatic castration-resistant prostate cancer
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
The project will generate and supply green energy to fulfill about 50% present consumption of the company
The scheme is subject to statutory and regulatory approvals as may be necessary.
He has published more than 100 research papers in several prestigious national and international journals
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Allam was serving recently as the CEO at Public Investment Fund
The camps were organised along with the doctors from Bharti Vidyapeeth Dental College and Hospital, Katraj, Pune, and Emcure’s occupational health centre (OHC) doctors
None of the observations are related to data integrity and management believes that they are addressable
Subscribe To Our Newsletter & Stay Updated